- Low
- 96,310
- Average
- 134,130
- Median
- 125,783
- High
- 195,500
Exelixis Salary
35
32
41
Exelixis average salary is $134,130, median salary is $125,783 with a salary range from $96,310 to $195,500.
Exelixis salaries are collected from government agencies and companies. Each salary is associated with a real job position. Exelixis salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Exelixis salaries are collected from government agencies and companies. Each salary is associated with a real job position. Exelixis salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Exelixis salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Exelixis Jobs
| See more Exelixis Jobs» | |
| Search All Jobs | |
Exelixis... Information
- Exelixis, Inc
- Industry: BioTech/Drugs
- City: So. San Francisco, CA
- Exelixis, Inc. is a biotechnology company focused on the discovery validation of novel targets for several major human diseases, and on the discovery of potential new drug therapies, specifically for cancer and other proliferative diseases. The Company is focused on the life sciences industries and development of proprietary drugs, through its experience in comparative genomics and model system genetics. The Company alsodevelops proprietary genetic, biochemical and cell-based assays for use in screening for potential targets, proteins and products.
